| abstract |
The invention concerns an oligosaccharide comprising uronic acid repeating units having an average molecular weight by weight comprised between 1,200 and 3,000 D and containing nitro groups -ONO2 covalently bonded to the saccharide structure, and pharmaceutical compositions comprising it. The oligosaccharide according to the invention is disclosed for use as a medicament, more specifically for use in the treatment and prevention of pathologies associated with disfunctions of haemostatic and cardiovascular systems. |